THERAPEUTIC POTENTIAL OF SELECTIVE D-1 DOPAMINE RECEPTOR AGONISTS AND ANTAGONISTS IN PSYCHIATRY AND NEUROLOGY

被引:48
作者
WADDINGTON, JL
机构
来源
GENERAL PHARMACOLOGY | 1988年 / 19卷 / 01期
关键词
D O I
10.1016/0306-3623(88)90005-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:55 / 60
页数:6
相关论文
共 50 条
[1]   SOME ATYPICAL NEUROLEPTICS INHIBIT [H-3] SCH 23390 BINDING INVIVO [J].
ANDERSEN, PH ;
NIELSEN, EB ;
GRONVALD, FC ;
BRAESTRUP, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 120 (01) :143-144
[2]   DOPAMINE D-1 RECEPTOR AGONISTS COMBINED WITH THE SELECTIVE D-2 AGONIST QUINPIROLE FACILITATE THE EXPRESSION OF ORAL STEREOTYPED BEHAVIOR IN RATS [J].
ARNT, J ;
HYTTEL, J ;
PERREGAARD, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 133 (02) :137-145
[3]   DOPAMINERGIC MECHANISMS AND MOTOR FUNCTION - CHARACTERIZATION OF D-1 AND D-2 DOPAMINE RECEPTOR INTERACTIONS [J].
BARONE, P ;
DAVIS, TA ;
BRAUN, AR ;
CHASE, TN .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 123 (01) :109-114
[4]  
BARONE P, 1986, CLIN NEUROPHARMACOL, V9, P128
[5]   SELECTIVE D-1 DOPAMINE RECEPTOR AGONIST TREATMENT OF PARKINSONS-DISEASE [J].
BRAUN, A ;
FABBRINI, G ;
MOURADIAN, MM ;
SERRATI, C ;
BARONE, P ;
CHASE, TN .
JOURNAL OF NEURAL TRANSMISSION, 1987, 68 (1-2) :41-50
[6]   OBLIGATORY D-1 D-2 RECEPTOR INTERACTION IN THE GENERATION OF DOPAMINE AGONIST RELATED BEHAVIORS [J].
BRAUN, AR ;
CHASE, TN .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 131 (2-3) :301-306
[7]  
BREESE GR, 1984, J PHARMACOL EXP THER, V231, P343
[8]  
BREESE GR, 1985, J PHARMACOL EXP THER, V235, P287
[9]  
BREESE GR, 1986, NEUROBIOLOGY CENTRAL
[10]   PHARMACOLOGICAL EFFECTS OF A SPECIFIC DOPAMINE D-1 ANTAGONIST SCH-23390 IN COMPARISON WITH NEUROLEPTICS [J].
CHRISTENSEN, AV ;
ARNT, J ;
HYTTEL, J ;
LARSEN, JJ ;
SVENDSEN, O .
LIFE SCIENCES, 1984, 34 (16) :1529-1540